QQ客服 官方微博 反馈留言

	A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
	Zhou, Caicun; Huang, Yunchao; Wang, Donglin; An, Changshan; Zhou, Fuxiang; Li, Yali; Chen, Gongyan; Wu, Changping; He, Jianxing; Wu, Gang
刊名	CLINICAL LUNG CANCER
	2016
卷号	17期号:2
关键词	Clinical trial Efficacy Granulocyte-colony stimulating factor Long-acting PEG-rhG-CSF Safety
ISSN号	1525-7304
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3428167
专题	昆明医科大学
推荐引用方式 GB/T 7714	Zhou, Caicun,Huang, Yunchao,Wang, Donglin,et al. A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)[J]. CLINICAL LUNG CANCER,2016,17(2).
APA	Zhou, Caicun.,Huang, Yunchao.,Wang, Donglin.,An, Changshan.,Zhou, Fuxiang.,...&Xia, Jielai.(2016).A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC).CLINICAL LUNG CANCER,17(2).
MLA	Zhou, Caicun,et al."A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)".CLINICAL LUNG CANCER 17.2(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。